Molecular Data Inc
NASDAQ:MKD
Molecular Data Inc
Income from Continuing Operations
Molecular Data Inc
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Molecular Data Inc
NASDAQ:MKD
|
Income from Continuing Operations
-¥328m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Income from Continuing Operations
¥96.5B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
16%
|
|
Pinduoduo Inc
NASDAQ:PDD
|
Income from Continuing Operations
¥60B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
JD Health International Inc
HKEX:6618
|
Income from Continuing Operations
¥383.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Meituan
HKEX:3690
|
Income from Continuing Operations
¥13.9B
|
CAGR 3-Years
43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
JD.Com Inc
HKEX:9618
|
Income from Continuing Operations
¥23.3B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Molecular Data Inc's Income from Continuing Operations?
Income from Continuing Operations
-328m
CNY
Based on the financial report for Dec 31, 2020, Molecular Data Inc's Income from Continuing Operations amounts to -328m CNY.
What is Molecular Data Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
-45%
Over the last year, the Income from Continuing Operations growth was -69%. The average annual Income from Continuing Operations growth rates for Molecular Data Inc have been -45% over the past three years .